Epidemiology and clinical manifestations of mucormycosis.

By G. Petrikkos, A. Skiada, O. Lortholary, E. Roilides, Thomas J. Walsh, D. Kontoyiannis. Clinical Infectious Diseases, 2012

1,274 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the infectious diseases society of America. (2014, background): “Aspergillus , Rhizopus , and Mucor species cause painful erythematous skin nodules that become necrotic and can resemble ecthyma gangrenosum because of their tendency for angioinvasion [222].”
ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013. (2014, background): “Recently, the different clinical manifestations have been reviewed [17].”
Global Epidemiology of Mucormycosis (2019, background): “In case of orbital and cerebral extension, the disease can be seen as orbital cellulitis, optic neuritis, soft tissue infiltration in the optical apex, bone rarefaction and erosion of the skull base, cavernous sinus and internal carotid artery thrombosis, infracts and intra-cranial abscess in the br”